891
Participants
Start Date
September 1, 2020
Primary Completion Date
April 28, 2021
Study Completion Date
July 28, 2021
SB206 10.3% berdazimer
Topically once daily
vehicle gel
Topically once daily
Site #265, Sugarloaf
Site #330, Rockville
Site #267, Richmond
Site #343, Morgantown
Site #279, Greensboro
Site #255, Summerville
Site #295, Fountain Inn
Site #116, Newnan
Site #335, Apopka
Site #227, Sanford
Site #341, Orlando
Site #314, Miami Lakes
Site #334, Homestead
Site #305, Tampa
Site #278, Miami
Site #333, Fort Lauderdale
Site #342, Boca Raton
Site #316, Murfreesboro
Site #291, Kingsport
Site #326, Knoxville
Site # 117, Louisville
Site #347, Lexington
Site #328, Bowling Green
Site #294, Owensboro
Site #310, Plainfield
Site #288, Evansville
Site #274, Clarkston
Site #121, New Brighton
Site #253, Rolling Meadows
Site #340, Chicago
Site #338, Omaha
Site #332, New Orleans
Site #297, New Orleans
Site# 349, Covington
Site #321, Baton Rouge
Site #101, Hot Springs
Site #272, Rogers
Site #299, Longview
Site #337, Houston
Site #224, San Antonio
Site #325, Greenwood Village
Site #281, Layton
Site #345, West Jordan
Site #312, Glendale
Site #327, Thousand Oaks
Site #161, San Diego
Site #336, Fountain Valley
Site# 348, Fresno
Site #329, Fremont
Site #250, Portland
Site #339, Spokane
Site #346, Brighton
Site #201, Berlin
Site #331, Verona
Site #311, Warwick
Therapeutics, Inc.
INDUSTRY
Synteract, Inc.
INDUSTRY
Novan, Inc.
INDUSTRY